FINAL BILL REPORT
This analysis was prepared by non-partisan legislative staff for the use of legislative members in their deliberations. This analysis is not a part of the legislation nor does it constitute a statement of legislative intent.
C 244 L 20
Synopsis as Enacted
Brief Description: Increasing access to medications for opioid use disorder.
Sponsors: Senate Committee on Behavioral Health Subcommittee to Health & Long Term Care (originally sponsored by Senators Hasegawa, Keiser, Kuderer and Nguyen).
Senate Committee on Health & Long Term Care
Senate Committee on Behavioral Health Subcommittee to Health & Long Term Care
House Committee on Health Care & Wellness
Background: The Pharmacy Quality Assurance Commission (PQAC) regulates the practice of pharmacy, and the distribution, manufacturing, and delivery of pharmaceuticals within and into the state. PQAC issues licenses, registrations, and certifications to qualified persons and entities and responds to complaints or reports of unprofessional conduct. Under current law, PQAC does not allow for the license of location for a pharmacy to be extended to a registered remote dispensing site.
Summary: The license of location for a pharmacy may be extended to a registered remote dispensing site that uses technology to dispense federally-approved medications for the treatment of opioid use disorder. The pharmacy must register each remote dispensing site with PQAC. PQAC must adopt rules that establish the minimum standards for registering remote dispensing sites, including who may retrieve medications stored in a remote dispensing site and the stocking and inventory responsibilities for the pharmacy. The Department of Health may adopt rules to establish a fee for obtaining and renewing the remote dispensing site registration.
Votes on Final Passage:
June 11, 2020